FDA Approves Supplement for Risperidone by Heritage Pharma
The FDA has approved a supplement for the ANDA076228 application for Risperidone submitted by Heritage Pharma.
Asset / Drug
Drug and asset intelligence for Risperidone with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
The FDA has accepted a supplemental application for Risperidone submitted by Actavis Labs.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.